UBS’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.18B Buy
11,028,066
+745,285
+7% +$77.3M 0.87% 6
2014
Q2
$1.08B Sell
10,282,781
-2,937
-0% -$297K 0.84% 5
2014
Q1
$1.01B Sell
10,285,718
-119,765
-1% -$11.1M 0.9% 8
2013
Q4
$953M Buy
10,405,483
+662,716
+7% +$61.1M 0.89% 8
2013
Q3
$845M Buy
9,742,767
+1,246,897
+15% +$112M 0.86% 9
2013
Q2
$729M Buy
+8,495,870
New +$721M 0.86% 7

Other funds holding JNJ

UBS's JNJ Position: Q3 2014 in Review

UBS increased its Johnson & Johnson (JNJ) stake by 7.2% in Q3 2014, buying an estimated $77.3M and bringing the position to 11,028,066 shares worth $1.18B. The position accounts for 0.87% of the portfolio, ranked #6.

UBS first reported a position in JNJ in Q2 2013 and has held it in 6 quarters since. 1,987 funds tracked by Wall St. Rank hold JNJ as of Q3 2014.

  • UBS held 11,028,066 shares of Johnson & Johnson worth $1.18B as of Q3 2014.
  • UBS bought 745,285 Johnson & Johnson shares in Q3 2014, an estimated $77.3M.
  • Johnson & Johnson made up 0.87% of UBS's portfolio in Q3 2014, its #6 holding.
  • UBS first reported a position in Johnson & Johnson in Q2 2013 and has held it in 6 quarters since.
  • 1,987 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.